CTI Biopharma: 17% Pullback In The Shares Makes For A Good Entry Point, Says Roth Capital http://www.smarteranalyst.com/2014/07/22/cti-biopharma-17-pullback-in-the-shares-makes-for-a-good-entry-point-says-roth-capital/